ABSTRACT. The structurally diverse xenobiotic peroxisome proliferators (PPs) increase the number of peroxisomes per cell and the levels of several enzymes, and cause hepatomegaly, often leading to hepatocarcinogenesis in a species-and tissue-specific manner. The deadlocked problems of the molecular mechanism of PP action and its physiological meanings have begun to be understood through CDNA cloning of a PP-activated receptor (PPAR). PPAR, a member of the steroid/thyroid/vitamin super family of nuclear receptors, has isoforms and differentially heterodimerizes with other nuclear receptors, providing potential mechanisms not only for speciesand tissue-specific actions but also for diverse actions of PPs. Recent findings related to PPAR are summarized, and its possible role in lipid metabolism and involvement in PP-induced hepatocarcinogenesis are discussed.
Peroxisomes are organdies that are involved in diverse functions, including the /S-oxidation of fatty acids (see Refs. 48, 51 for reviews). They are found in most eukaryotic cells and their essential role has been emphasized by the discoveries of several human disorders caused by the lack of peroxisomes (see Ref. 49 for review) . In addition to containing H2O2-producing oxidases (12), peroxisomes are unique for their ability to proliferate in response to several structurally disparate chemicals, which are designated "peroxisome proliferators (PPs)", in rodent liver cells (51, 77) (see Fig. 1 ). All the structurally diverse PPs are thought to induce peroxisomal gene transcription through the same mechanism (75). A receptor-mediated mechanism hypothesis was presented and biochemical approaches were made to detect the PP receptor. Although a specific binding Abbreviations used: PP, peroxisome proliferator; PPAR, PP-activated receptor; 643 , -(2,3-xylidino)-2-pyrimidinylthio]acetic acid; DEHP, di(2-ethylhexyl)phthalate; PPRE, PP response element; DR-n, direct repeat separated by n base pairs; RXR, retinoid X receptor; RAR, retinoic acid receptor; VDR, vitamin D receptor; TR, thyroid receptor; TRE, thyroid hormone response element; RXRE, retinoid X response element; ARP-1 , apoAI regulatory protein-1 ; HNF, hepatocyte nuclear factor.
for PPs (43, 44, but also see Ref. 58 ) and purification of the binding protein (2) were reported, further characterization which would facilitate our understanding of the mechanism of the PP action has been unsuccessful. The recent isolation and characterization of the PP-activated receptor (PPAR) CDNA (30), which was unexpected by most researchers in this field, was a breakthrough in our knowledge of the molecular mechanism of the transcriptional activation by PPs and the endogenous significance of the regulation by the receptor. This review highlights these findings and discusses the possible diverse actions of PPs with emphasis on their role(s) in PP-induced hepatocarcinogenesis, because another important aspect of PPs is that they cause hepatomegaly and several of them are non-genotoxic but have hepatocarcinogenic properties (see Refs. 60, 74 for reviews). In 1990, Issemann and Green (30) reported CDNA cloning of a new member in the steroid/thyroid/vitamin super family of nuclear receptors.
With neither information on the actual ligand for the receptor nor the binding DNA element, they hypothesized a steroid hormone-like mechanism for the PP action and isolated three new receptor CDNA clones from a mouse CDNA library using only the information on the amino acid conservation in the DNA-binding domain of the super family members (15, 47 Fig. 2 . The number of amino acids between the first two of the four conserved Cys residues in the second zinc-binding site of all PPARs is three instead of five as found in all other nearly 40 (47) members of this family except the tailless orphan receptor which has seven residues (71). The sequence homologies in the domains of PPARs are high enough to distinguish them from other members of the super family, but the differences among PPAR isoforms are not as evident. Isoform classification of mammalian PPARs relative to Xenopus a, /3 and y receptor (14) PPAR is thought to have two binding sites: one for a specific DNA element and another for an in vivo ligand, but neither was known at the time of CDNA cloning. This element has been found not only in the rodent acyl CoA oxidase genes but also in other PP inducible genes such as 3-ketoacyl-CoA thiolase (27), enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase (54, 96, 98) , cytochrome P450IV family (5, 65), fatty acid binding protein (6, 31, 91) and malic enzyme (26).
Interestingly, PPRE is indistinguishable from the previously identified retinoid X response element (RXRE) (53) (see Fig. 4 ). RXR has already been characterized to form heterodimers with VDR (vitamin D), TR (thyroid hormone) and RAR (retinoic acid), and to bind cooperatively to their cognate response elements (38, 39, 88) . It was therefore plausible to test the possibility that PPAR can be a counterpart of an RXR heterodimer. Thus, mouse RXRa has been shown to be almost essential for the binding of PPARa to PPRE, exerting ligand-dependent synergistic activation of the PPRE-containing promoters (3, 20, 32, 40, 97 ) (see Fig. 4 ). Heterodimer formation and synergistic interaction between Xenopus PPARa and mouse RXR/3 (35) were also demonstrated.
In vitro binding and in vivo co-transfection studies showed that the PPARa-RXRa complex has a preference for the direct repeat separated by 1 bp. PPAR may form heterodimers with other nuclear receptors, and differential heterodimerization of PPAR with various receptors provides a potential mechanism for not only specific but also diverse actions of PPs as discussed below.
It should be noted, however, that PPAR-RXR heterodimerization has not been demonstrated in the cell containing normal levels of these factors. In this context, the result of Osumi et al. (69) , showing that a few adjacent nucleotides downstream to the PPRE of the rat acyl CoA oxidase gene were essential for the PP-mediated transcriptional activation in hepatoma cells transfected only with the target gene, is interesting. Specificity and diversity of PP action. Species-and tissue-specific action is characteristic of PPs and the presence of PPAR must be involved in these specificities (23). Sex differences in the effects of PPs in one species are also evident and the activation of PPAR must be further modulated in a sex-dependent manner. The mechanistic analyses so far carried out have been limited to the core of transcriptional activation of the genes in lipid metabolism by PPAR, and only the characteristics of their specificity have been focused on to date. The extensive deletion analysis of the rat acyl CoA oxidase gene promoter by Osumi et al. (69) suggested the existence of a few DNA elements other than PPRE functioning positively or negatively. In addition to a counterpart of the heterodimer of the PPAR, many other protein factors will bind to the complex and the upstream elements of the PP-responsive promoter in a species-and tissue-specific manner, exerting specific expression of the gene depending on PPs. Extensive studies of other cis-and trans-diCtmg factors are necessary and the issue of transcriptional regulation by PPAR has thus become one problem which involves a member of the steroid/thyroid/vitamin super family.
Most studies on the effects of PPs previously conducted have been focused on the specific and stimulatory action, primarily on peroxisomal gene expression or enzyme activities. However, analyses of other effects, which are not necessarily the result of peroxisome prolif- by acting with or without the aid of PPAR in various steps (see Fig. 5 ), and this model is in c ontrast to previous one-site acting models (see below).
Chronic administration of PP often causes development of hepatocellular carcinomas in rats and mice. Wy-14,643, a potent PP at 0.1% in the diet for 60 weeks, for example, resulted in a 100% incidence of rats with liver tumors (45). Classical genotoxic assays such as the Ames test have shown that PPs are non-genotoxic carcinogens.
As the mechanism of liver carcinogenicity of PP, Reddy and Rao (74, 76) suggested the oxidative stress hypothesis that emphasized an imbalance in the induced levels of H2O2-producing peroxisomal oxidases and decomposing catalase activities. PP is regarded as a tumor initiator in this hypothesis. Cattley and co-workers (8, 56), on the contrary, suggested that PP may cause promotion of spontaneously initiated response rather than initiating the hepatocarcinogenic response in rodents. Despite much research, controversy remains as to whether PP-induced hepatocarcinogenicity is due to one of these causes, to both of them or to other causes, and the basic mechanism of the (probable) multistage carcinogenesis is unknown (60). It is clear that there is no definitive association between peroxisome proliferation and hepatocarcinogenesis. Bezafibrate was reported as a potent PP but not carcinogenic (16, 24), and DEHP is known to produce far fewer hepatocarcinomas than Wy-14,643 does at doses causing comparable peroxisome proliferation (41 , 45, 56) . Thus peroxisome proliferation alone is not sufficient for carcinogenesis.
But this does not exclude the possibility that PPs have initiating activity. Oxidative damage or other causes induced by peroxisome proliferation may play a role in the initiation step. A small increase in DNA adducts in rat liver by long-term exposure to a PP was reported (34). Furthermore, some PPs may exert initiating activity independently from peroxisome proliferation although most previous experiments for detecting initiating activity of PPs were negative (9, 18, 94) . Recent studies measuring sister chromatid exchange, micronuclei formation and chromosomal aberrations as the genotoxic endpoints (28), in contrast to the Ames test, showed that several PPs including clofibrate, DEHP, Wy-14,643, nafenopin and ciprofibrate produced weak but significant genotoxic effects in primarily cultured hepatocytes (28, 78) and in hamster embryo cells (86) within a few hours, suggesting their actions were without transcriptional activation. The increase of replicative DNA synthesis in isolated hepatocytes within a few hours after administration of PPs to rats was also reported (89, 90). It is noteworthy that no clear relationship among induction of peroxisome proliferation, carcinogenicity in vivo, and genotoxicity in cultured cells has been observed. Furthermore, genotoxicity of PPs was also detected in human hepatocytes (28) where no peroxisome proliferation was observed. These results are inconsistent with a model of a single action in the initiation step even after the genotoxicity of PPs is established. Species-and tissue-specific carcinogenic properties of PPs do not seem to related to their genotoxicity.
PPs also may act as tumor promoters by modulating the expression of the genes involved in growth and differentiation. It is well known that PPs cause hepatic cell hyperplasia in a species-specific manner. The major objection to their having an important role in proliferative activities would be that a greatly decreased hyperplasia occurring after a transient increase only in the early phase of administration of PP cannot account for their critical role in carcinogenesis (74). Popp and colleagues (10, 56, 92) and another group (4), however, reported the increased proliferative activities of the carcinogenic PPs even in chronically PP-administered animals. Wy-14,643 actually promoted carcinogenesis in diethylnitrosamine (DEN)-initiated rat livers (10). Moreover, it would not be general hyperplasia but an activity to stimulate the proliferation of the initiated cells that plays a key role in carcinogenesis.
The target genes to alter the pathways allowing for the selective growth of the initiated cells in PP-induced hepatocarcinogenesis have not been identified. Various changes in many pathways create the potential to allow enhanced proliferation of and also inhibition of apoptosis of the initiated cells (82), but the number of studies to find such PP-induced changes is limited. Bieri (7) reported that fos, Ha-ras1, and raf were activated by PPs and the levels of the mRNAs remained high as long as the PP treatment was prolonged. None of these properties of PPs alone can quantitatively explain their species-and tissue-specific carcinogenicity. It seems to be important to consider the possibility that many PPs have some degree of both properties and their coupled actions effectively or ineffectively cause hepatocarcinoma.
Interestingly, recent studies suggest that the cells under proliferation are much more sensitive to the exposure of very low doses of general genotoxic carcinogens (ll, 33) . Several PPs may be too weak in genotoxicity to give a positive detection, yet their associated species-specific function mediated by PPAR to enhance cellular proliferation of the initiated cells would make those PPs species-specific carcinogens.
The peroxisome has occasionally been put in the spotlight by the discovery of the presence of a /3-oxidation system in it, the carcinogenic properties of PPs, and the discovery of several human disorders caused by the lack of it.
However, the organelle has not claimed any general interest.
The 
